Kaya Holdings (KAYS) Shares Outstanding (Weighted Average) (2011 - 2025)

Kaya Holdings (KAYS) recorded quarterly Shares Outstanding (Weighted Average) of $147.8 million in Q3 2025, up 246.44% quarter-over-quarter from $42.7 million in Q2 2025, and up 507.58% on a YoY basis from $24.3 million in Q3 2024.

Kaya Holdings (KAYS) Shares Outstanding (Weighted Average) (2011 - 2025) Analysis & Trends

Kaya Holdings' Shares Outstanding (Weighted Average) history runs 15 years deep, the most recent figure standing at $147.8 million for Q3 2025.

  • In Q3 2025, Shares Outstanding (Weighted Average) rose 507.58% year-over-year to $147.8 million; the TTM figure through Sep 2025 stood at $147.8 million (up 507.58% YoY), while the FY2024 annual figure was $28.4 million, up 28.12% from the prior year.
  • Shares Outstanding (Weighted Average) was $147.8 million for Q3 2025 at Kaya Holdings, up from $42.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $185.8 million in Q1 2024 to a low of $316158.0 in Q3 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $35.4 million across 5 years, with a median of $22.2 million in 2023.
  • The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Weighted Average) sank 97.89% in 2022, then soared 6913.21% in 2023.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $14.8 million in 2021, then advanced by 1.96% to $15.0 million in 2022, then jumped by 47.28% to $22.2 million in 2023, then rose by 28.12% to $28.4 million in 2024, then soared by 420.49% to $147.8 million in 2025.
  • The last three Shares Outstanding (Weighted Average) figures came in at $147.8 million (Q3 2025), $42.7 million (Q2 2025), and $42.7 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 1.16 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 43.50 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 5.02 Bn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 100.50 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 166.20 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 64.74 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 228.36 Mn
10 Kaya Holdings - - 5,370.00 147.81 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 147.81 Mn
Jun 30, 2025 42.66 Mn
Mar 31, 2025 42.67 Mn
Dec 31, 2024 28.40 Mn
Sep 30, 2024 24.33 Mn
Jun 30, 2024 22.17 Mn
Mar 31, 2024 185.80 Mn
Dec 31, 2023 22.16 Mn
Sep 30, 2023 22.17 Mn
Jun 30, 2023 22.17 Mn
Mar 31, 2023 22.17 Mn
Dec 31, 2022 15.05 Mn
Sep 30, 2022 316,158.00
Jun 30, 2022 737,703.00
Mar 31, 2022 14.72 Mn
Dec 31, 2021 14.76 Mn
Sep 30, 2021 15.01 Mn
Jun 30, 2021 15.01 Mn
Mar 31, 2021 14.33 Mn
Dec 31, 2020 737,703.00